pcDNA3.1-CoV2-Omicron BA.1 spike
(Plasmid
#194602)
-
PurposeMammalian expression of RBD domain from SARS-CoV-2 omicron (BA.1)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 194602 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCDNA3.1
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameCoV2-Omicron BA.1 spike
-
SpeciesSevere acute respiratory syndrome coronavirus 2
-
Entrez GeneS (a.k.a. GU280_gp02, spike glycoprotein)
Cloning Information
- Cloning method Gibson Cloning
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3.1-CoV2-Omicron BA.1 spike was a gift from Ben Murrell (Addgene plasmid # 194602 ; http://n2t.net/addgene:194602 ; RRID:Addgene_194602) -
For your References section:
Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study. Sheward DJ, Kim C, Ehling RA, Pankow A, Castro Dopico X, Dyrdak R, Martin DP, Reddy ST, Dillner J, Karlsson Hedestam GB, Albert J, Murrell B. Lancet Infect Dis. 2022 Jun;22(6):813-820. doi: 10.1016/S1473-3099(22)00129-3. Epub 2022 Mar 17. 10.1016/S1473-3099(22)00129-3 PubMed 35305699